Atria Investments’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.34M | Buy |
10,674
+1,415
| +15% | +$178K | 0.02% | 903 |
|
|
2025
Q1 | $1.02M | Buy |
9,259
+4,164
| +82% | +$461K | 0.01% | 981 |
|
|
2024
Q4 | $695K | Sell |
5,095
-400
| -7% | -$54.6K | 0.01% | 1157 |
|
|
2024
Q3 | $633K | Sell |
5,495
-1,307
| -19% | -$151K | 0.01% | 1214 |
|
|
2024
Q2 | $936K | Buy |
+6,802
| New | +$936K | 0.01% | 974 |
|
|
2021
Q2 | – | Sell |
-10,710
| Closed | -$1.04M | – | 780 |
|
|
2021
Q1 | $1.04M | Buy |
+10,710
| New | +$1.04M | 0.02% | 690 |
|